Shimadzu Receives Vizient Contract for Cardiac and Vascular Interventional Systems and General Radiology Systems

Shimadzu Medical Systems USA, a leading manufacturer of advanced medical X-ray imaging systems, has announced that the Trinias unity edition product line has been awarded a contract from Vizient, Inc., the nation’s largest health care performance improvement company, effective September 1, 2021.

The agreement for Trinias unity edition product line, which consists of the Cardiac and Vascular Interventional digital angiography systems, offers enhanced savings to Vizient members.

The Trinias unity edition is available in several configurations with both Floor and Ceiling mounted C-Arms to meet both Cardiac and Vascular requirements with a range of flat panel detectors, including 8″,12″ and 16″ sizes. Bi-Plane configurations for 8″ and 12″ are also available for Cardiac and Neurology. “Shimadzu intraoperative x-ray systems have some unique features that improve both operator efficiency and workflow as well as patient comfort and safety,” says Tim Stevener, Shimadzu’s Director of the IXR product line. Stevener goes on to say, “exclusive features like reciprocal space mapping-digital angiography system provides incredible images even if the patient unexpectantly moves, while STENTVIEW, using artificial intelligence, allows the physician to visualize even the smallest wires and stents used.”

Shimadzu currently has general diagnostic X-ray imaging equipment on contract with Vizient and available for purchase, and has been awarded a new agreement for these products that is effective on Oct 1, 2021, offering the following systems:

  • RADspeed PRO radiographic systems series featuring POWERGLIDE
  • MobileDaRt MX8 DR mobiles with Canon or Konica FPD’s
  • SONIALVISION G4LX – Advanced Universal RF system
  • FLUOROspeed X1 – Patient-side RF Table System

Tom Kloetzly, Vice President of National Sales and Marketing states, “With the contract for the Trinias unity edition, Shimadzu’s complete X-ray product portfolio is available to Vizient members nationally at contracted pricing.”

Vizient is the largest member-driven performance improvement company in the country. Vizient’s diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers. Vizient membership represents more than $110 billion in annual purchasing volume.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.